The Puzzling Prognostic Effect of LDH in Melanoma
Although LDH is a negative prognostic factor in melanoma, patients who receive checkpoint inhibitors may still have responses of long duration even when their LDH level is high. (Source: Medscape Oncology)
Source: Medscape Oncology - March 6, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Recurrent Colon Cancer: Location, Location, Location
Tumor location, whether on the right or left side of the colon, seems to affect the prognosis and aggressiveness of recurrent colorectal cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - February 27, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Low Recurrence After Risk-Reducing Surgery for BRCA Carriers
Dr Maurie Markman discusses the results of an RRSO surgery study showing a 1% incidence rate in long-term follow-up of subsequent peritoneal cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - February 24, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Practice Pearls: Checkpoint Inhibitors for Lung Cancer
Dr Mark Kris reviews the challenges of using newly approved immunotherapies for lung cancer patients, especially how to identify patients who will benefit and monitor their progress. (Source: Medscape Oncology)
Source: Medscape Oncology - February 23, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Crowdsourcing: A New Era in Breast Cancer Research
Over 3000 patients have responded to an online request from Boston researchers to contribute tumor tissue and saliva for the purpose of accelerating research on metastatic breast cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - February 13, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Sharing Genetic Data With Study Participants
Dr Maurie Markman explains that sharing genetic data with study participants encourages greater clinical trial involvement. (Source: Medscape Oncology)
Source: Medscape Oncology - January 31, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Endocrine Therapy in Breast Cancer: Best Bet on Duration
Dr Harold Burstein reviews the latest data on duration of adjuvant endocrine therapy in metastatic breast cancer, and provides much-needed recommendations on how to approach the topic with patients. (Source: Medscape Oncology)
Source: Medscape Oncology - December 19, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Myeloma Data at ASH 2016 Focus on Novel Combinations
The presentations at ASH 2016 for multiple myeloma focused on novel drug combinations in various settings, including newly diagnosed myeloma and refractory disease. (Source: Medscape Oncology)
Source: Medscape Oncology - December 12, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
